Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

He Huang

4PUBLICATIONS
5CO-AUTHORS
Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Feb 18, 2025
CircCCNB1 inhibits vasculogenic mimicry by sequestering NF90 to promote miR-15b-5p and miR-7-1-3p processing in nasopharyngeal carcinoma.

Chunmei Fan, Fenghua Tan, Jie Wu

|Jul 11, 2023
Preliminary study on the mechanism of POFUT1 in colorectal cancer.

Nianfeng Zhang, Linna Long, Guang Li

|Feb 06, 2023
The research status and prospects of MUC1 in immunology.

Linna Long, Xueying Huang, Siying Yu

|Feb 10, 2022
FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription.

Youxiang Hou, Zhanfei Dong, Wei Zhong

Pageof 1

Frequent Collaborators

1 joint publications

Youxiang Hou

1 joint publications

Gulina Kuerban

1 joint publications

Zhaoyang Zeng

1 joint publications

Wenjia Guo

1 joint publications

Wei Xiong

Frequent Collaborators

1 joint publications

Youxiang Hou

1 joint publications

Gulina Kuerban

1 joint publications

Zhaoyang Zeng

1 joint publications

Wenjia Guo

Top Related Videos

A Matrigel-Based Tube Formation Assay to Assess the Vasculogenic Activity of Tumor Cells
04:00

A Matrigel-Based Tube Formation Assay to Assess the Vasculogenic Activity of Tumor Cells

Published on : Sep 07, 2011

66.2K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on : Jul 28, 2010

12.4K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

21.3K
See more related videos

Top Related Videos

A Matrigel-Based Tube Formation Assay to Assess the Vasculogenic Activity of Tumor Cells
04:00

A Matrigel-Based Tube Formation Assay to Assess the Vasculogenic Activity of Tumor Cells

Published on : Sep 07, 2011

66.2K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on : Jul 28, 2010

12.4K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

21.3K
See more related videos